Skip to main content

Table 5 Patients studied – site of infection

From: A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay

Infecting organism

Total no. of patients in this category

Number of patients suitable for switch to oral therapy (% of patients with this infecting organism)

Number of patients suitable for switch to oral therapy and early discharge (% of patients with this infecting organism)

Coagulase negative staph

44

13 (30%)

9 (21%)

Enterococcus

17

5 (29%)

4 (24%)

MRSA

110

63 (57%)

38 (36%)

Other organisms

7

3 (43%)

3 (43%)

Culture negative

33

9 (27%)

8 (24%)

 

Total = 211

93

62